Preview Mode Links will not work in preview mode

May 25, 2023

Featuring perspectives from Dr John N Allan, Ms Jacqueline Broadway‑Duren, Ms Corinne Hoffman and Dr Adam S Kittai, including the following topics:

  • Introduction (0:00)
  • Overview of Chronic Lymphocytic Leukemia (CLL) (5:20)
  • First-Line Therapy for CLL (32:06)
  • Use of Venetoclax in Combination with an Anti-CD20 Antibody (49:16)
  • Choice of BTK Inhibitor; BTK Inhibitor Toxicity (1:14:33)
  • Noncovalent BTK Inhibitors (1:18:53)
  • CAR T-Cell Therapy; Transformation (1:23:08)

NCPD information and select publications